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 Recent work in the area of protein encapsulation has turned away from traditional 
methods of sequestration toward gentler, purely aqueous techniques. Among them, 
complex coacervation has become a topic of discussion. Complex coacervation is an all-
aqueous liquid-liquid phase separation phenomenon dominated by electrostatic 
interactions and entropic gains. The use of coacervates as protein encapsulants has 
garnered much attention, but there has been little headway in determining a set of design 
rules. We considered coacervation between two oppositely-charged polypeptides and a 
biomacromolecule cargo to investigate the effects of changing aspects of the coacervating 
polymers and/or various solution parameters. We characterized the level of encapsulation 
and partitioning of three different model proteins as a function of ionic strength, pH, 
polymer chain length, and polymer charge density. Our results highlighted the 
importance of electrostatic interactions in driving protein uptake into the coacervate 
phase. While intuitive effects such as increasing protein charge facilitating uptake and 
increased salt concentration decreasing uptake due to electrostatic screening effects, we 
determined that the net charge and the distribution of charges on both the protein and the 
polymers dominated protein incorporation. For example, the presence of a cluster of 
cationic residues on the surface of lysozyme resulted in several orders of magnitude 
 vii 
higher protein incorporation than was observed for serum albumin and hemoglobin, 
which have a more isotropic distribution of charges. We confirmed this trend, comparing 
the encapsulation of two variants of caspase-6 with the variant with a cationic charge 
patch yielding a higher encapsulation efficiency than the other. 
In addition to facilitating aqueous encapsulation of proteins, we hypothesize that 
complex coacervation can help to enhance the thermal stability of protein cargo through a 
combination of physical crowding and “soft” chemical interactions that mimic the 
naturally crowded environment of the cytosol. We tested this hypothesis using two model 
viruses, porcine parvovirus (PPV), a non-enveloped virus, and bovine viral diarrhea virus 
(BVDV), an envelope-virus. Accelerated aging studies at 60°C over the course of seven 
days demonstrated that coacervate encapsulation allowed PPV to retain more than three 
log higher levels of activity as compared to free virus in solution. For BVDV we did not 
observe significant stabilization, although we posit that this may be due to the presence of 
the envelope, which might already provide such protection. Overall, these preliminary 
results, obtained without considering the chemistry of the polymers, indicate the potential 
for using complex coacervation to enhance the shelf life of vaccines and biologics. This 
work sets the stage for future efforts geared towards understanding the specific ways in 
which the coacervate environment can affect protein and/or virus activity, including the 
potential for solvent removal.  
These results for PPV indicate the potential uses of complex coacervates in 
applications such as drug delivery and therapeutics. However, the applicability of 
complex coacervates is not limited to the liquid phase. We explored the ability to 
electrospin solid fibers of a two-protein heteroprotein coacervate. These results give 
 viii 
useful insight as to how therapeutic protein-containing complex coacervates might be 
formulated and then processed for applications such as advanced wound dressings. 
Beyond protein encapsulation, we explored the kinetics of binary complex 
coacervation utilizing a liquid handling robot. We were able to monitor the complexation 
of two peptides over time through turbidity measurements. These data described how 
factors such as system asymmetry and the addition of buffer or salt play critical roles in 
the complexation of two peptides. We also examined the phase behavior of more 
complex systems of two industrial polymers and a mixture of surfactants. Together, we 
garnered a broader understanding of the phase space of complexation with an emphasis 
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